EIR Document: KBI Biopharma, Inc., Jan 13, 2022

Name: FDA EIR KBI Biopharma, Durham | January 2022
Brand: U.S. FDA
Price: 995 USD
Availability: InStock

Establishment Inspection Report for the FDA inspection at KBI Biopharma, Inc.'s Durham site on Jan 13, 2022. Get detailed insights.